Fresenius SE & Co. KGaA (FSNUY)
OTCMKTS · Delayed Price · Currency is USD
14.48
+0.16 (1.12%)
Jan 8, 2026, 11:16 AM EST
Fresenius SE & Co. KGaA Market Cap
Fresenius SE & Co. KGaA has a market cap or net worth of $32.25 billion as of January 9, 2026. Its market cap has increased by 64.65% in one year.
Market Cap
32.25B
Enterprise Value
46.00B
Revenue
26.33B
Ranking
n/a
PE Ratio
24.05
Stock Price
$14.48
Market Cap Chart
Since April 23, 1997, Fresenius SE & Co. KGaA's market cap has increased from 2.17B to 32.25B, an increase of 1,386.34%. That is a compound annual growth rate of 9.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 32.25B | -0.61% |
| Dec 30, 2025 | 32.45B | 65.57% |
| Dec 30, 2024 | 19.60B | 12.16% |
| Dec 29, 2023 | 17.48B | 10.60% |
| Dec 30, 2022 | 15.80B | -29.41% |
| Dec 30, 2021 | 22.38B | -13.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 824.30M |
| Glass House Brands | 723.98M |
| Elite Pharmaceuticals | 506.04M |
| Northwest Biotherapeutics | 405.74M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 352.88M |
| Silence Therapeutics | 273.96M |